Inhibition of SIRT6 in prostate cancer reduces cell viability and increases sensitivity to chemotherapeutics

著录项

• 来源
  《蛋白质与细胞》 |2013年第9期|702-710|共9页
• 作者

  Yewei Liu; Qian Reuben Xie; Boshi Wang; Jiaxiang Shao; Tingting Zhang; Tengyuan Liu; Gang Huang;

  展开▼
• 作者单位

  School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai 200030, China;

  Department of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China;

  School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai 200030, China;

  School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai 200030, China;

  School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai 200030, China;

  School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai 200030, China;

  School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai 200030, China;

  Department of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China;

  展开▼
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词